January 20, 2017
Japanese MHLW OK’s Bayer’s cancer drug
Japanese Ministry of Health, Labour and Welfare (MHLW) has granted priority review to Bayer Yakuhin for regorafenib in the second-line…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
January 20, 2017
Latvian Olainfarm sales up by 39% year to year, target topped by 6%
According to preliminary consolidated results of Latvian JSC Olainfarm for December 2016, sales of the Groups have reached €10.28 million, which represents an increase by 39% compared to December 2015.
January 19, 2017
FDA approves Allergan’s skin disease drug
U.S. Food and Drug Administration (FDA) has approved Allergan’s Rhofade skin desease cream, a topical treatment of persistent facial erythema (redness)…
January 19, 2017
Anavex secures cash to study Anavex 2-73 for Rett syndrome
Anavex has ensured most of the cash for a U.S. multicentre Phase 2 clinical trial of Rett syndrome treatment Anavex2-73.
January 19, 2017
NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit
NeuroVive Pharmaceutical’s abstract with novel preclinical cancer data related to the company’s sanglifehrin-based compounds has been accepted for presentation at…
January 19, 2017
Summit Therapeutics’s R&D adviser becomes COO, President of Research Development
Summit Therapeutics has named its research and development adviser Dr David Roblin as new Chief Operating Officer (COO) and President of Research Development.
January 19, 2017
PledPharma’s Nomination Committee wants board changes
PledPharma’s Nomination Committee has submitted a proposal for a new composition of the Board of Directors for consideration at an…
January 19, 2017
GSK takes AstraZeneca’s European Executive Vice President to its team
GlaxoSmithKline has appointed Luke Miels President, Global Pharmaceuticals, GSK. He will be responsible for a portfolio of medicines and vaccines with annual sales of more than £15 billion and operations in over 100 markets.
January 19, 2017
Adocia plans private placement, wants to partner up on “more mature projects”
French drugmaker Adocia, encouraged by the outcome of its project BC Lispro, has set its goal on partnering up with companies that have “more mature projects”, such is Eli Lilly with whom Adocia worked on BC Lispro.
January 18, 2017
FDA warns Horizon Pharmaceuticals about drug products contamination
Horizon Pharmaceuticals has warned by the Food and Drug Administration (FDA) to better respond on resolving certain issues it had in its drug manufacturing facilities, that the FDA pointed out after an inspection in 2015.